143 related articles for article (PubMed ID: 36383247)
1. Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report.
Xue X; Fu L; Qiu T; Cao Z; Wang X; Rao W; Luo Y; He L; Feng X
Virchows Arch; 2023 Jul; 483(1):111-116. PubMed ID: 36383247
[TBL] [Abstract][Full Text] [Related]
2. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
Khanlari M; Medeiros LJ; Lin P; Xu J; You MJ; Tang G; Yin CC; Wang W; Qiu L; Miranda RN; Bueso-Ramos CE; Li S
Mod Pathol; 2022 Mar; 35(3):419-426. PubMed ID: 34608246
[TBL] [Abstract][Full Text] [Related]
3. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
4. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
5. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
[TBL] [Abstract][Full Text] [Related]
6. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
7. Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas.
Johnson PC; Abramson JS
Oncology (Williston Park); 2022 Aug; 36(8):499-505. PubMed ID: 36001789
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of Burkitt's lymphoma.
Dave SS; Fu K; Wright GW; Lam LT; Kluin P; Boerma EJ; Greiner TC; Weisenburger DD; Rosenwald A; Ott G; Müller-Hermelink HK; Gascoyne RD; Delabie J; Rimsza LM; Braziel RM; Grogan TM; Campo E; Jaffe ES; Dave BJ; Sanger W; Bast M; Vose JM; Armitage JO; Connors JM; Smeland EB; Kvaloy S; Holte H; Fisher RI; Miller TP; Montserrat E; Wilson WH; Bahl M; Zhao H; Yang L; Powell J; Simon R; Chan WC; Staudt LM;
N Engl J Med; 2006 Jun; 354(23):2431-42. PubMed ID: 16760443
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
[TBL] [Abstract][Full Text] [Related]
10. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
11. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.
Li S; Qiu L; Xu J; Lin P; Ok CY; Tang G; McDonnell TJ; James You M; Khanlari M; Miranda RN; Medeiros LJ
Leukemia; 2023 Feb; 37(2):422-432. PubMed ID: 36513804
[TBL] [Abstract][Full Text] [Related]
12. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
Ennishi D; Jiang A; Boyle M; Collinge B; Grande BM; Ben-Neriah S; Rushton C; Tang J; Thomas N; Slack GW; Farinha P; Takata K; Miyata-Takata T; Craig J; Mottok A; Meissner B; Saberi S; Bashashati A; Villa D; Savage KJ; Sehn LH; Kridel R; Mungall AJ; Marra MA; Shah SP; Steidl C; Connors JM; Gascoyne RD; Morin RD; Scott DW
J Clin Oncol; 2019 Jan; 37(3):190-201. PubMed ID: 30523716
[TBL] [Abstract][Full Text] [Related]
13. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
[TBL] [Abstract][Full Text] [Related]
14. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
15. Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.
Scholtysik R; Kreuz M; Klapper W; Burkhardt B; Feller AC; Hummel M; Loeffler M; Rosolowski M; Schwaenen C; Spang R; Stein H; Thorns C; Trümper L; Vater I; Wessendorf S; Zenz T; Siebert R; Küppers R;
Haematologica; 2010 Dec; 95(12):2047-55. PubMed ID: 20823134
[TBL] [Abstract][Full Text] [Related]
16. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
17. Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
Kuhlman JJ; Moustafa MA; Jiang L; Iqbal M; Seegobin K; Wolcott Z; Ayala E; Ansell S; Rosenthal A; Paludo J; Micallef I; Johnston P; Inwards D; Habermann T; Kharfan-Dabaja M; Witzig TE; Nowakowski GS; Tun HW
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e815-e825. PubMed ID: 35534379
[TBL] [Abstract][Full Text] [Related]
18. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.
Gutiérrez MI; Bhatia K; Cherney B; Capello D; Gaidano G; Magrath I
Ann Oncol; 1997 Oct; 8(10):987-94. PubMed ID: 9402172
[TBL] [Abstract][Full Text] [Related]
19. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
[TBL] [Abstract][Full Text] [Related]
20. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
